Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention

  Liver Diseases

  Free Subscription


1 Am J Gastroenterol
2 Am J Pathol
2 Biochem Biophys Res Commun
3 BMC Cancer
3 BMC Gastroenterol
1 Cancer
1 Cancer Res
1 Endoscopy
2 Gut
1 Hepatology
1 J Gastroenterol Hepatol
5 J Hepatol
2 PLoS One
2 Radiology
2 Transplant Proc

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Am J Gastroenterol

  1. KRAMER JR, Cao Y, Li L, Smith D, et al
    Longitudinal Associations of Risk Factors and Hepatocellular Carcinoma in Patients With Cured Hepatitis C Virus Infection.
    Am J Gastroenterol. 2022;117:1834-1844.
    PubMed         Abstract available

    Am J Pathol

  2. JABER FL, Sharma Y, Gupta S
    Hepatocyte Transplantation Rebalances Cytokines for Hepatic Regeneration in Rats with Ataxia Telangiectasia Mutated Pathway-Related Acute Liver Failure.
    Am J Pathol. 2022 Oct 27. pii: S0002-9440(22)00318.
    PubMed         Abstract available

  3. LUNA-MARCO C, Ubink A, Kopsida M, Heindryckx F, et al
    Endoplasmic Reticulum Stress and Metabolism in Hepatocellular Carcinoma.
    Am J Pathol. 2022 Oct 26. pii: S0002-9440(22)00322.
    PubMed         Abstract available

    Biochem Biophys Res Commun

  4. IQBAL T, Nawaz A, Karim M, Yaku K, et al
    Loss of hepatic Nmnat1 has no impact on diet-induced fatty liver disease.
    Biochem Biophys Res Commun. 2022;636.
    PubMed         Abstract available

  5. WANG Q, Zheng K, Tan D, Liang G, et al
    TREM2 knockdown improves the therapeutic effect of PD-1 blockade in hepatocellular carcinoma.
    Biochem Biophys Res Commun. 2022;636.
    PubMed         Abstract available

    BMC Cancer

  6. DAI Q, Song F, Li X, Huang F, et al
    Comprehensive analysis of the expression and prognosis for IQ motif-containing GTPase-activating proteins in hepatocellular carcinoma.
    BMC Cancer. 2022;22:1121.
    PubMed         Abstract available

  7. ABD-RABOU AA, Ahmed HH, Kishta MS
    Implication of extrinsic and intrinsic apoptotic pathways in the targeted therapy of hepatocellular carcinoma using aptamer-labeled viramidine nanoparticles.
    BMC Cancer. 2022;22:1106.
    PubMed         Abstract available

  8. ZHANG G, Zhang K, Zhao Y, Yang Q, et al
    A novel stemness-hypoxia-related signature for prognostic stratification and immunotherapy response in hepatocellular carcinoma.
    BMC Cancer. 2022;22:1103.
    PubMed         Abstract available

    BMC Gastroenterol

  9. LIU HL, Yang AY, Xiong QF, Zhong YD, et al
    Aberrant cytokeratin 7 expression by hepatocytes can predict the ductopenia grade in primary biliary cholangitis.
    BMC Gastroenterol. 2022;22:443.
    PubMed         Abstract available

  10. CHEN W, Hong D, Chen Z, Dai X, et al
    Gamma-glutamyl transpeptidase to platelet and gamma-glutamyl transpeptidase to lymphocyte ratio in a sample of Chinese Han population.
    BMC Gastroenterol. 2022;22:442.
    PubMed         Abstract available

  11. GU X, Zhang S, Yang X, Guan T, et al
    Drug-related adverse events potentially predict the efficacy of apatinib on advanced hepatocellular carcinoma.
    BMC Gastroenterol. 2022;22:441.
    PubMed         Abstract available


    Blood-based test to predict future risk of developing liver cancer: Researchers recently discovered a genetic signature that can help predict long-term hepatocellular carcinoma risk in patients who have nonalcoholic fatty liver disease, and may also h
    Cancer. 2022;128:3904.

    Cancer Res

  13. ZHU X, Song G, Zhang S, Chen J, et al
    Asialoglycoprotein Receptor 1 Functions as a Tumor Suppressor in Liver Cancer via Inhibition of STAT3.
    Cancer Res. 2022;82:3987-4000.
    PubMed         Abstract available


  14. GRALNEK IM, Camus Duboc M, Garcia-Pagan JC, Fuccio L, et al
    Endoscopic diagnosis and management of esophagogastric variceal hemorrhage: European Society of Gastrointestinal Endoscopy (ESGE) Guideline.
    Endoscopy. 2022;54:1094-1120.
    PubMed         Abstract available


  15. THEVENOT T, Desmarets M, Weil D, Di Martino V, et al
    Diameter of the shunt: the missing link in the appraisal of pTIPS in patients with cirrhosis with previous hepatic encephalopathy.
    Gut. 2022 Nov 3. pii: gutjnl-2022-328761. doi: 10.1136/gutjnl-2022-328761.

  16. RUDLER M, Hernandez-Gea V, Procopet BD, Giraldez A, et al
    Hepatic encephalopathy is not a contraindication to pre-emptive TIPS in high-risk patients with cirrhosis with variceal bleeding.
    Gut. 2022 Sep 9. pii: gutjnl-2022-326975. doi: 10.1136/gutjnl-2022-326975.
    PubMed         Abstract available


  17. FOUAD Y, Abdel Dayem WA, Mehrez M
    Letter to the editor: Apples should be compared with apples.
    Hepatology. 2022;76:E101.

    J Gastroenterol Hepatol

  18. ALMOMANI A, Kumar P, Onwuzo S, Boustany A, et al
    Epidemiology and Prevalence of Lean Non-Alcoholic Fatty Liver Disease and Associated Cirrhosis, HCC and Cardiovascular Outcomes in the United States: A Population-Based Study and Review of Literature.
    J Gastroenterol Hepatol. 2022 Nov 3. doi: 10.1111/jgh.16049.
    PubMed         Abstract available

    J Hepatol

  19. TRANAH TH, Ballester MP, Carbonell-Asins JA, Jalan R, et al
    Reply to 'The possible link between higher ammonia levels associated with non-alcoholic fatty liver related cirrhosis and diabetes: are we missing chronic kidney disease?'
    J Hepatol. 2022 Nov 1. pii: S0168-8278(22)03161.

  20. SPOSITO C, Ratti F, Cucchetti A, Ardito F, et al
    Survival benefit of adequate lymphadenectomy in patients undergoing liver resection for clinically node negative intrahepatic cholangiocarcinoma.
    J Hepatol. 2022 Oct 31. pii: S0168-8278(22)03158.
    PubMed         Abstract available

  21. NOUREDDIN M, Harrison SA
    NASH Cirrhosis Trials And Major Adverse Liver Outcomes: Big Data Needed.
    J Hepatol. 2022 Oct 31. pii: S0168-8278(22)03159.

  22. CABIBBO G, Bruix J
    Radiological endpoints as surrogates for survival benefit in Hepatocellular Carcinoma trials: all that glitters is not gold.
    J Hepatol. 2022 Oct 30. pii: S0168-8278(22)03155.

  23. LI B, Hong C, Fan Z, Cai S, et al
    Prognostic and therapeutic significance of microbial cell-free DNA in plasma of people with acutely decompensated cirrhosis.
    J Hepatol. 2022 Oct 26. pii: S0168-8278(22)03144.
    PubMed         Abstract available

    PLoS One

  24. CHIDLOW SJ, Randle LE, Kelly RA
    Predicting physiologically-relevant oxygen concentrations in precision-cut liver slices using mathematical modelling.
    PLoS One. 2022;17:e0275788.
    PubMed         Abstract available

  25. LIN N, Wang L, Huang Q, Zhou W, et al
    A simplified model for prophylactic transarterial chemoembolization after resection for patients with hepatocellular carcinoma.
    PLoS One. 2022;17:e0276627.
    PubMed         Abstract available


  26. YOON JH
    A Placebo Effect on MRI Proton Density Fat Fraction in Nonalcoholic Steatohepatitis Trials.
    Radiology. 2022 Nov 1:222295. doi: 10.1148/radiol.222295.

  27. NEDRUD MA, Chaudhry M, Middleton MS, Moylan CA, et al
    MRI Quantification of Placebo Effect in Nonalcoholic Steatohepatitis Clinical Trials.
    Radiology. 2022 Nov 1:220743. doi: 10.1148/radiol.220743.
    PubMed         Abstract available

    Transplant Proc

  28. GOMEZ PASANTES D, Rivas Polo JI, Taboada Ameneiro M, Aguirrezabalaga Gonzalez J, et al
    Diaphragmatic Hernia Post Liver Transplant With Thrombosis of the Hepatic Artery Due to Median Arcuate Ligament Syndrome: A Case Report.
    Transplant Proc. 2022 Oct 31. pii: S0041-1345(22)00617.
    PubMed         Abstract available

  29. DAHIYA M, Omar M, Hussaini T, Lan J, et al
    Isolated Hepatic Chronic Ductopenic Rejection Requiring Liver Retransplant in the Absence of Kidney Graft Rejection After Combined Liver-Kidney Transplant: A Case Report.
    Transplant Proc. 2022 Oct 31. pii: S0041-1345(22)00689.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Liver Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.